CClinicalTrials.gg
TerminatedNCT01658111MITEEGUpdated Oct 3, 2022

Robot-aided Therapy in Stroke Patients for Upper Limb Rehabilitation

An interventional study of Robot Group and Traditional physiotherapy in Stroke, sponsored by IRCCS San Raffaele Roma. Terminated at 2 sites in Italy. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2022-10-03.

Sponsored by IRCCS San Raffaele Roma · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Numerous studies showed that ascertaining the effectiveness of rehabilitative interventions on conditions leading to long-term disability, such as stroke, is a complex task because the outcome depends on many interacting factors. Several studies underline the importance of brain plasticity and its therapeutic potential in neurological disorders. Accredited theories of cortical reorganization after brain lesion endorse the use of early, intensive, repetitive, and context-related exercise as optimal strategies to promote motor relearning and minimize motor deficit. The use of robotic systems in upper limb motor rehabilitation programs has been already demonstrated to provide safe and intensive treatment to subjects with motor impairments due to a neurological injury: several studies showed the advantages of robotic therapy on chronic post-stroke patients, even if no consistent influence on functional abilities was found and evidence of better results providing intensive treatments, both robotic and conventional rehabilitative techniques, was found. Recent development and recent trial in robot-assisted rehabilitation has shown the great potential of robotic devices for delivering repetitive training, thus facilitating a high intensity and a large dose of training during sub-acute and chronic phases of stroke rehabilitation. The proposed project, through a randomized controlled observer-blind multicenter trial is aimed at evaluating the effectiveness of robot-assisted therapy as additional treatment to the standard physical therapy in the early phase after stroke onset and evaluating in conjunction with EEG and EMG recordings the effects of the rehabilitative treatments in a quantitative, measurable way, by providing reliable and objective methods for measuring functional recovery after stroke.

Read the detailed description

The main original contribution of this project is to provide an experimental framework, based on proximal robotic treatment approach, to test whether starting with the distal robot-assisted sensorimotor therapy the effective in improving motor functions of sub-acute stroke patients.

The use of robotic platforms to administer the rehabilitation therapy is crucial for two main reasons:

  1. the physical therapies based on robotic platforms assure that each patient in the same testing group is treated in the same repeatable way, eliminating the intrinsic subject-dependent variability that affects traditional therapies;
  2. the robotic platforms, in conjunction with EEG and EMG recordings, can be used to assess the effects of the rehabilitative treatments in a quantitative, measurable way, by providing reliable and objective methods for measuring functional recovery after stroke.
02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • Robots
  • EEG
  • EMG
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 50 is close to the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

IRCCS San Raffaele Roma is the lead sponsor of 63 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • first acute event of cerebrovascular stroke
  • unilateral paresis,
  • ability to understand and follow simple instructions,
  • ability to remain in a sitting posture, even through seat belts for trunk fixation.

Exclusion criteria

Exclusion Criteria:

  • bilateral impairment,
  • severe sensory deficits in the paretic upper limb,
  • cognitive impairment or behavioral dysfunction that would influence the ability to comprehend or perform the experiment,
  • refusal or inability to provide informed consent
  • other current severe medical problems.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Traditional physiotherapy

    Each subject will receive 4 weeks of traditional upper limb rehabilitation treatment (20 sessions, 5 days a week for 4 weeks).

    Procedure: Traditional physiotherapy

  • Experimental
    Robot Group

    Each subject will be asked to perform five sessions per week goal-directed, planar reaching tasks, which emphasizes shoulder and elbow movements, moving from the centre target to each of 8 peripheral targets equally spaced on a 0.14 m radius circumference around a centre target using the InMotion2 (IM2) system (20 sessions- 5 days a week for 4 weeks).

    Device: Robot Group

Interventions

  • DeviceRobot Group

    The MIT-MANUS/InMotion2 (Interactive Motion Technologies, Inc., Watertown, MA, USA) system has two translational degrees of freedom (dof): shoulder abduction-adduction (ab-ad), elbow flexion-extension (flexext). The robotic system supports the execution of reaching movements in the horizontal plane through an assist as needed control strategy. The robot can guide the movement of the upper limb of the patients and record end-effector physical quantities such as the position, velocity, and applied forces. The device is designed to have a low intrinsic end-point impedance (i.e., be back-drivable to easily carry the weight of the patient's arm, to execute movements without constraint and offer minimal resistance. A 3-dof force transducer is placed at the robots end-effector, as well.

    Also known as: MIT-MANUS/InMotion2

  • ProcedureTraditional physiotherapy

    Active or passive exercises.

    Also known as: FKT

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Fugl-Meyer Scale at 28 weeks.

    Time frame: at inclusion, week 4 and week 28

  2. Change from Baseline in Box and Block Test at 28 weeks.

    Time frame: at inclusion, week 4 and week 28.

Secondary outcomes

  1. Change from Baseline in Modified Ashworth Scale at 28 weeks.

    Time frame: at inclusion, week 4 and week 28.

Other outcomes

  1. Change from Baseline in Frenchay Arm Test at 28 weeks.

    Time frame: at inclusion, week 4 and week 28.

07

Study locations

2 sites
  • IRCCS San Raffaele Roma
    Roma, 00161, Italy
  • Auxilium Viate Volterra
    Volterra, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01658111
Lead sponsor
IRCCS San Raffaele Roma
Responsible party
Sponsor
First posted
Aug 6, 2012
Start date
Jul 2012
Primary completion
Jul 2013
Completion
Aug 2014
Last update
Oct 3, 2022

Study contacts

Michela Goffredo, BME
principal investigator · IRCCS San Raffaele Rome

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion